Changes in Malondialdehyde, 8-iso-prostaglandin F2α, and Lipid Profiles Among COVID-19 Patients: Findings from South-Western Nigeria - Top-Institutions - MDSpire

Changes in Malondialdehyde, 8-iso-prostaglandin F2α, and Lipid Profiles Among COVID-19 Patients: Findings from South-Western Nigeria

  • By

  • Maria Onomhaguan Ebesunun

  • Donatus Uchechukwu Ozegbe

  • Promise Chineye Nwaejigh

  • Bose Etaniamhe Orimadegun

  • Obiageri Ihuarulam Okeoma

  • January 20, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Lipidomics
    • Oxidative Stress Research

  • #2

    University of Oxford
    University of Oxford

    Oxford, UK

    Key Differentiators

    • Clinical Infectious Diseases
    • Metabolic Research
    • Inflammation

  • #3

    National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute
    National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute

    Bethesda, MD

    Key Differentiators

    • Cardiovascular Research
    • Oxidative Stress
    • Lipid Metabolism

  • #4

    University of Lagos
    University of Lagos

    Lagos, Nigeria

    Key Differentiators

    • Infectious Diseases
    • Clinical Biochemistry
    • Public Health

  • #5

    University of Cape Town
    University of Cape Town

    Cape Town, South Africa

    Key Differentiators

    • Infectious Diseases
    • Metabolic Research
    • Oxidative Stress

Original Source(s)

Changes in Malondialdehyde, 8-iso-prostaglandin F2α, and Lipid Profiles Among COVID-19 Patients: Findings from South-Western Nigeria

  • by Maria Onomhaguan Ebesunun, Donatus Uchechukwu Ozegbe, Promise Chineye Nwaejigh, Bose Etaniamhe Orimadegun, Obiageri Ihuarulam Okeoma

  • January 20, 2026

Related Content

Early ICU Rehab Backed, With Caveats

Invited narrative review supports early, interprofessional rehabilitation across the ICU recovery continuum while emphasizing heterogeneous evidence and inconsistent implementation worldwide.

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.